TRIACORT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triacort, and what generic alternatives are available?
Triacort is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in TRIACORT is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Triacort
A generic version of TRIACORT was approved as triamcinolone acetonide by TARO on October 1st, 1986.
Summary for TRIACORT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Patent Applications: | 3,303 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRIACORT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRIACORT
US Patents and Regulatory Information for TRIACORT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solvay | TRIACORT | triamcinolone acetonide | CREAM;TOPICAL | 087113-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |